Back to Journals » International Journal of Women's Health » Volume 10

Intrapartum fetal heart rate monitoring using a handheld Doppler versus Pinard stethoscope: a randomized controlled study in Dar es Salaam

Authors Kamala BA, Kidanto HL, Wangwe PJ, Dalen I, Mduma ER, Perlman JM, Ersdal HL

Received 23 December 2017

Accepted for publication 11 May 2018

Published 9 July 2018 Volume 2018:10 Pages 341—348

DOI https://doi.org/10.2147/IJWH.S160675

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 3

Editor who approved publication: Professor Elie Al-Chaer


Benjamin A Kamala,1,2 Hussen L Kidanto,3,4 Peter J Wangwe,2,5 Ingvild Dalen,3 Estomih R Mduma,3,6 Jeffrey M Perlman,7 Hege L Ersdal1,8

1
Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; 2Department of Obstetrics and Gynecology, Muhimbili National Hospital, Dar es Salaam, Tanzania; 3Department of Research, Stavanger University Hospital, Stavanger, Norway; 4School of Medicine, Aga Khan University, Dar es Salaam, Tanzania; 5Department of Obstetrics and Gynecology, Muhimbili University of Health and Allied Science, Dar es Salaam, Tanzania; 6Department of Research, Haydon Lutheran Hospital, Manyara, Tanzania; 7Department of Pediatrics, Weill Medical College, New York, NY, USA; 8Department of Anesthesiology and Intensive Care, Stavanger University Hospital, Stavanger, Norway

Background: Fetal stethoscopes are mainly used for intermittent monitoring of fetal heart rate (FHR) during labor in low-income countries, where perinatal mortality is still high. Handheld Dopplers are rarely available and are dependent on batteries or electricity. The objective was to compare the Pinard stethoscope versus a new wind-up handheld Doppler in the detection of abnormal FHR.
Materials and methods: We conducted a randomized controlled study at Muhimbili National Hospital, Tanzania, from April 2013 to September 2015. Women with gestational age ≥37 weeks, cephalic presentation, normal FHR on admission, and cervical dilatation <7 cm were included. Primary outcome was abnormal FHR detection (<120 or >160 beats/min). Secondary endpoints were time to delivery, mode of delivery, and perinatal outcomes. χ2, Fisher’s exact test, Mann–Whitney test, and logistic regression were conducted. Unadjusted and adjusted odds ratios were calculated with respective 95% confidence interval.
Results: In total, 2,844 eligible women were assigned to FHR monitoring with Pinard (n=1,423) or Doppler (n=1,421). Abnormal FHRs were more often detected in the Doppler (6.0%) versus the Pinard (3.9%) arm (adjusted odds ratio =1.59, 95% confidence interval: 1.13–2.26, p=0.008). Median (interquartile range) time from abnormal FHR detection to delivery was comparable between Doppler and Pinard, ie, 80 (60,161) and 89 (52,165) minutes, respectively, as was the incidence of cesarean delivery (12.0% versus 12.2%). The incidence of adverse perinatal outcomes (fresh stillbirths, 24-hour neonatal admissions, and deaths) was similar overall; however, among newborns with abnormal FHR delivered vaginally, adverse outcomes were less incident in Doppler (7 of 43 births, 16.3%) than in the Pinard arm (10 of 23 births, 43.5%), p=0.021.
Conclusion: Intermittent FHR monitoring using Doppler was associated with an increased detection of abnormal FHR compared to Pinard in a low-risk population. Time intervals from abnormal FHR detection to delivery were longer than recommended in both arms. Perinatal outcomes were better among vaginally delivered newborns with detected abnormal FHR in the Doppler arm.

Keywords: fetal heart rate, perinatal outcomes, Pinard stethoscope, Doppler

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]